Synektik SA

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: PLSNKTK00019
PLN
296.00
8.6 (2.99%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Strong Long Term Fundamental Strength with a 69.14% CAGR growth in Operating Profits

  • Company has a low Debt to Equity ratio (avg) at times
  • The company has been able to generate a Return on Capital Employed (avg) of 81.43% signifying high profitability per unit of total capital (equity and debt)
2

Flat results in Dec 25

3

With ROE of 54.71%, it has a attractive valuation with a 11.31 Price to Book Value

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

PLN 2,567 Million (Mid Cap)

stock-summary
P/E

21.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

3.57%

stock-summary
Debt Equity

-0.58

stock-summary
Return on Equity

52.29%

stock-summary
Price to Book

9.94

Revenue and Profits:
Net Sales:
228 Million
(Quarterly Results - Dec 2025)
Net Profit:
43 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
9.39%
0%
9.39%
6 Months
22.42%
0%
22.42%
1 Year
43.0%
0%
43.0%
2 Years
133.07%
0%
133.07%
3 Years
544.18%
0%
544.18%
4 Years
1047.29%
0%
1047.29%
5 Years
953.38%
0%
953.38%

Synektik SA for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
42.10%
EBIT Growth (5y)
69.14%
EBIT to Interest (avg)
19.18
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.82
Sales to Capital Employed (avg)
3.12
Tax Ratio
20.17%
Dividend Payout Ratio
89.72%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
81.43%
ROE (avg)
23.83%

Valuation key factors

Factor
Value
P/E Ratio
21
Industry P/E
Price to Book Value
11.31
EV to EBIT
15.95
EV to EBITDA
13.86
EV to Capital Employed
13.51
EV to Sales
3.42
PEG Ratio
0.73
Dividend Yield
3.25%
ROCE (Latest)
84.69%
ROE (Latest)
54.71%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Bullish
OBV
Mildly Bearish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 14.46% vs 29.18% in Sep 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 9.39% vs 29.18% in Sep 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "228.00",
          "val2": "199.20",
          "chgp": "14.46%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "60.00",
          "val2": "54.50",
          "chgp": "10.09%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.80",
          "val2": "0.80",
          "chgp": "125.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "43.10",
          "val2": "39.40",
          "chgp": "9.39%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "236.90%",
          "val2": "247.10%",
          "chgp": "-1.02%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Sep 2025 is 9.17% vs 39.65% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Sep 2025 is 51.57% vs 57.33% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "681.30",
          "val2": "624.10",
          "chgp": "9.17%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "178.30",
          "val2": "123.70",
          "chgp": "44.14%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3.10",
          "val2": "1.40",
          "chgp": "121.43%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-1.30",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "125.20",
          "val2": "82.60",
          "chgp": "51.57%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "231.40%",
          "val2": "171.80%",
          "chgp": "5.96%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQstock-summary

Dec'25
Sep'25
Change(%)
Net Sales
228.00
199.20
14.46%
Operating Profit (PBDIT) excl Other Income
60.00
54.50
10.09%
Interest
1.80
0.80
125.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
43.10
39.40
9.39%
Operating Profit Margin (Excl OI)
236.90%
247.10%
-1.02%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2025 is 14.46% vs 29.18% in Sep 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2025 is 9.39% vs 29.18% in Sep 2025

Annual Results Snapshot (Consolidated) - Sep'25stock-summary

Sep'25
Sep'24
Change(%)
Net Sales
681.30
624.10
9.17%
Operating Profit (PBDIT) excl Other Income
178.30
123.70
44.14%
Interest
3.10
1.40
121.43%
Exceptional Items
0.00
-1.30
100.00%
Consolidate Net Profit
125.20
82.60
51.57%
Operating Profit Margin (Excl OI)
231.40%
171.80%
5.96%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Sep 2025 is 9.17% vs 39.65% in Sep 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Sep 2025 is 51.57% vs 57.33% in Sep 2024

stock-summaryCompany CV
About Synektik SA stock-summary
stock-summary
Synektik SA
Pharmaceuticals & Biotechnology
Synektik SA is a Poland-based company active in the medical sector. It produces PACS software which allows running a diagnostic imaging laboratory. It runs a research laboratory which performs acceptance and specialist tests of X-ray equipment. The Company sells medical equipment and operates a services center for imaging equipment. Synektik SA is a partner of Siemens. On November 28, 2013, the Company raised its stake in Miedzynarodowe Centra Medyczne Inwestycje Sp z o o to 100%.
Company Coordinates stock-summary
Company Details
Al. Witosa 31 , WARSZAWA None : 00-710
stock-summary
Tel: 48 22 3270900
stock-summary
Registrar Details